Open AccessSafety, Tolerability, and Efficacy of Raltegravir in a Diverse Cohort of HIV-Infected Patients: 48-Week Results from the REALMRK Study
Author(s) -
Kathleen Squires,
Linda Gail Bekker,
Joseph J. Eron,
Benjamin S. Cheng,
Juergen Rockstroh,
F.L. Barragán Márquez,
Princy Kumar,
Melanie Thompson,
Rafael Campo,
Karam Mounzer,
Kim M. Strohmaier,
Chengxing Lu,
Anthony Rodgers,
Beth Jackson,
Larissa Wenning,
Michael J. Robertson,
Bach Nguyen,
Peter Sklar
Publication year - 2013
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/erbm-f902
Subject(s) - raltegravir , tolerability , medicine , human immunodeficiency virus (hiv) , cohort , pharmacology , virology , antiretroviral therapy , adverse effect , viral load